Sarcura

Sankt Andra-wordern, Austria Founded: 2019 • Age: 7 yrs
Cell therapy solutions for multiple therapeutic areas are developed.
Request Access

About Sarcura

Sarcura is a company based in Sankt Andra-wordern (Austria) founded in 2019 by Erwin Gorjup, Daniela Buchmayr, Franz Emminger, and Martin Fischlechner.. Sarcura has raised $10.24 million across 4 funding rounds from investors including European Union, Austria Wirtschaftsservice and HCVC. Sarcura operates in a competitive market with competitors including Lunaphore, Parallel Fluidics, CellFE, Lightcast Discovery and Hummingbird Nano, among others.

  • Headquarter Sankt Andra-wordern, Austria
  • Founders Erwin Gorjup, Daniela Buchmayr, Franz Emminger, Martin Fischlechner
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.24 M (USD)

    in 4 rounds

  • Latest Funding Round
    $80.58 K (USD), Grant

    Jun 01, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Sarcura
Headcount 10-50
Employee Profiles 18
Employee Profiles
People
Lukas Vik
Senior Staff Engineer- Digital Design
People
Fernando Garcia
Development Engineer Fluidics
People
Erwin Gorjup
Co- Founder & Chief Scientific Officer
People
Jana Buchmayr
Research Scientist

Unlock access to complete

Funding Insights of Sarcura

Sarcura has successfully raised a total of $10.24M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $80.58 thousand completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $80,576
  • First Round

    (19 Nov 2020)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2023 Amount Grant - Sarcura Valuation

investors

Nov, 2022 Amount Seed - Sarcura Valuation Lansdowne Partners , xista
Nov, 2020 Amount Seed - Sarcura Valuation Nina Capital , Axilium Holding
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sarcura

Sarcura has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Austria Wirtschaftsservice and HCVC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are directed toward hard-tech and full-stack companies by HCVC.
Founded Year Domain Location
Innovative technologies and startups are supported with capital and expertise.
Founded Year Domain Location
Early-stage technology and life science startups are supported by investments.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sarcura

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Sarcura

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sarcura Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sarcura

Sarcura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lunaphore, Parallel Fluidics, CellFE, Lightcast Discovery and Hummingbird Nano, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Microfluidic-based instruments for tumor analysis are developed.
domain founded_year HQ Location
Microfluidic chips are provided for research labs using embossing technology.
domain founded_year HQ Location
Intracellular gene delivery platform is developed using microfluidic devices.
domain founded_year HQ Location
Advanced single-cell analysis solutions are provided for biotechnology research.
domain founded_year HQ Location
Manufacturer of microfluidic chips
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sarcura

Frequently Asked Questions about Sarcura

When was Sarcura founded?

Sarcura was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Sarcura located?

Sarcura is headquartered in Sankt Andra-wordern, Austria. It is registered at Sankt Andra-wordern, Niederosterreich, Austria.

Who is the current CEO of Sarcura?

Daniela Buchmayr is the current CEO of Sarcura. They have also founded this company.

Is Sarcura a funded company?

Sarcura is a funded company, having raised a total of $10.24M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.97M, raised on Nov 19, 2020.

What does Sarcura do?

Founded in 2019 and based in Sankt Andra Wordern, Austria, cell therapy manufacturing systems are developed by Sarcura for personalized treatments across various therapeutic sectors. Silicon and microfluidic structures are utilized to process cells at an individual level, while modular designs enable customized process configurations and operational adaptability in the biotechnology field.

Who are the top competitors of Sarcura?

Sarcura's top competitors include CellFE, Parallel Fluidics and Lightcast Discovery.

Who are Sarcura's investors?

Sarcura has 9 investors. Key investors include European Union, Austria Wirtschaftsservice, HCVC, tecnet, and Lansdowne Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available